<DOC>
	<DOCNO>NCT00921804</DOCNO>
	<brief_summary>The purpose study determine whether treatment daily oral dose AZD8529 40 mg administer 28 day safe , well tolerated improves main symptom schizophrenia adult schizophrenia patient .</brief_summary>
	<brief_title>Study Assess Efficacy , Safety , Tolerability AZD8529 Adult Schizophrenia Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Patient need read , understand sign inform consent prior study specific procedure Patient certain schizophrenia symptom deem investigator appropriate study entry Patients exclude base recent history significant illness current disease assess investigator screen process ( base physical examination , laboratory study electrocardiogram study ) Patients excluded urine drug screen test show positive result Smoking 2 pack cigarette day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Hallucinations</keyword>
	<keyword>Paranoia</keyword>
	<keyword>Inpatient schizophrenia clinical trial</keyword>
</DOC>